FGFR2 INHIBITOR COMPOUNDS

The present invention provides compounds of the formula (I):, or a pharmaceutically acceptable salt thereof, wherein A, X1, X2, X3, Y, Z, Z1, Z2, R2 and R6 are as defined herein, for use in the treatment of cancer and a method of treating cancer. La présente invention concerne des composés de formul...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	METCALF, Andrew Terrance, GARCIA LOSADA, Pablo, PRIETO VALLEJO, Maria Lourdes, DEL PRADO CATALINA, Miriam Filadelfa, VALERO DE LA CRUZ, Alberto, ADEVA BARTOMOLE, Marta, GARCIA-CERRADA, Susana Maria, MARTINEZ PEREZ, Jose Antonio, FERNANDEZ FIGUEROA, Maria Carmen, GARZÓN SANZ, Miguel, PEIRÓ CADAHIA, Jorge, GUTIERREZ SANFELICIANO, Sonia Maria
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention provides compounds of the formula (I):, or a pharmaceutically acceptable salt thereof, wherein A, X1, X2, X3, Y, Z, Z1, Z2, R2 and R6 are as defined herein, for use in the treatment of cancer and a method of treating cancer. La présente invention concerne des composés de formule (I) : ou un sel pharmaceutiquement acceptable de ceux-ci, A, X1, X2, X3, Y, Z, Z1, Z2, R2 et R6 étant tels que définis dans la description, destinés à être utilisés dans le traitement du cancer et une méthodes de traitement du cancer.